Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP931258.RAAgrvhbAwI1UoO3HP0dzTAwj64ctEeV8eC2XqZgYnhUg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP931258.RAAgrvhbAwI1UoO3HP0dzTAwj64ctEeV8eC2XqZgYnhUg130_assertion type Assertion NP931258.RAAgrvhbAwI1UoO3HP0dzTAwj64ctEeV8eC2XqZgYnhUg130_head.
- NP931258.RAAgrvhbAwI1UoO3HP0dzTAwj64ctEeV8eC2XqZgYnhUg130_assertion description "[VEGF immunoreactivity was correlated with poor tumor grade (p?=?0.0074), hormone receptors negativity (p?=?0.0206, p?=?0.0002 respectively), and MIB-1-labeling index (p?=?0.0044) in familial cancers (BRCA1-2 and BRCAX).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP931258.RAAgrvhbAwI1UoO3HP0dzTAwj64ctEeV8eC2XqZgYnhUg130_provenance.
- NP931258.RAAgrvhbAwI1UoO3HP0dzTAwj64ctEeV8eC2XqZgYnhUg130_assertion evidence source_evidence_literature NP931258.RAAgrvhbAwI1UoO3HP0dzTAwj64ctEeV8eC2XqZgYnhUg130_provenance.
- NP931258.RAAgrvhbAwI1UoO3HP0dzTAwj64ctEeV8eC2XqZgYnhUg130_assertion SIO_000772 23326384 NP931258.RAAgrvhbAwI1UoO3HP0dzTAwj64ctEeV8eC2XqZgYnhUg130_provenance.
- NP931258.RAAgrvhbAwI1UoO3HP0dzTAwj64ctEeV8eC2XqZgYnhUg130_assertion wasDerivedFrom befree-20150227 NP931258.RAAgrvhbAwI1UoO3HP0dzTAwj64ctEeV8eC2XqZgYnhUg130_provenance.
- NP931258.RAAgrvhbAwI1UoO3HP0dzTAwj64ctEeV8eC2XqZgYnhUg130_assertion wasGeneratedBy ECO_0000203 NP931258.RAAgrvhbAwI1UoO3HP0dzTAwj64ctEeV8eC2XqZgYnhUg130_provenance.